To further address the relevance of IL-1 signaling in MPN pathogenesis, we analyzed previously published gene expression microarray dataset of peripheral blood CD34+ HSPCs from JAK2-V617F+ PMF patients and bone marrow CD34+ HSPCs from normal controls19. This evidence concerns the gene JAK2 and myeloproliferative disorder.